Agilon Health (AGL) Competitors $1.32 +0.10 (+7.72%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$1.30 -0.02 (-1.51%) As of 08/22/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AGL vs. PGNY, CELC, ARDT, PACS, NHC, VRDN, AVAH, TDOC, AHCO, and OMDAShould you be buying Agilon Health stock or one of its competitors? The main competitors of Agilon Health include Progyny (PGNY), Celcuity (CELC), Ardent Health (ARDT), PACS Group (PACS), National HealthCare (NHC), Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), Teladoc Health (TDOC), AdaptHealth (AHCO), and Omada Health (OMDA). These companies are all part of the "healthcare" industry. Agilon Health vs. Its Competitors Progyny Celcuity Ardent Health PACS Group National HealthCare Viridian Therapeutics Aveanna Healthcare Teladoc Health AdaptHealth Omada Health Progyny (NASDAQ:PGNY) and Agilon Health (NYSE:AGL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations. Is PGNY or AGL more profitable? Progyny has a net margin of 4.28% compared to Agilon Health's net margin of -5.35%. Progyny's return on equity of 10.69% beat Agilon Health's return on equity.Company Net Margins Return on Equity Return on Assets Progyny4.28% 10.69% 7.12% Agilon Health -5.35%-66.76%-17.47% Does the media favor PGNY or AGL? In the previous week, Progyny had 4 more articles in the media than Agilon Health. MarketBeat recorded 16 mentions for Progyny and 12 mentions for Agilon Health. Progyny's average media sentiment score of 1.21 beat Agilon Health's score of 0.36 indicating that Progyny is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Progyny 11 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 2 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, PGNY or AGL? Progyny has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProgyny$1.17B1.73$54.34M$0.5939.88Agilon Health$6.06B0.09-$260.15M-$0.77-1.72 Do analysts rate PGNY or AGL? Progyny currently has a consensus target price of $25.10, suggesting a potential upside of 6.67%. Agilon Health has a consensus target price of $3.07, suggesting a potential upside of 131.81%. Given Agilon Health's higher probable upside, analysts plainly believe Agilon Health is more favorable than Progyny.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Progyny 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.73Agilon Health 2 Sell rating(s) 12 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.11 Do institutionals & insiders believe in PGNY or AGL? 94.9% of Progyny shares are held by institutional investors. 9.4% of Progyny shares are held by insiders. Comparatively, 3.6% of Agilon Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, PGNY or AGL? Progyny has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, Agilon Health has a beta of 0.14, suggesting that its share price is 86% less volatile than the S&P 500. SummaryProgyny beats Agilon Health on 15 of the 17 factors compared between the two stocks. Get Agilon Health News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricAgilon HealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$509.74M$7.70B$5.76B$20.94BDividend YieldN/A2.71%4.41%3.58%P/E Ratio-1.7278.4731.1029.11Price / Sales0.0949.18434.9252.98Price / CashN/A24.6737.7323.54Price / Book1.3424.799.535.45Net Income-$260.15M$243.33M$3.26B$992.10M7 Day Performance19.37%1.08%2.10%2.61%1 Month Performance-42.01%-0.65%2.82%1.46%1 Year Performance-70.36%10.34%30.56%10.72% Agilon Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLAgilon Health2.6617 of 5 stars$1.33+7.7%$3.07+131.8%-70.5%$509.74M$6.06B-1.721,076News CoverageAnalyst ForecastPGNYProgyny2.4041 of 5 stars$23.78+1.6%$24.90+4.7%+11.9%$2.04B$1.17B40.31310News CoveragePositive NewsAnalyst ForecastCELCCelcuity1.1516 of 5 stars$51.57-0.4%$50.60-1.9%+210.5%$2.01BN/A-14.9540Short Interest ↑ARDTArdent Health3.4105 of 5 stars$12.64+1.2%$19.56+54.8%-24.0%$1.81B$5.97B6.9824,900Positive NewsPACSPACS Group2.6336 of 5 stars$11.44-0.6%$33.33+191.5%-70.0%$1.74B$3.11B0.0032,433Upcoming EarningsNHCNational HealthCareN/A$107.76+0.2%N/A-11.8%$1.67B$1.46B13.5012,400News CoverageVRDNViridian Therapeutics1.5836 of 5 stars$18.11-2.3%$37.00+104.3%+25.4%$1.48B$300K-4.7350AVAHAveanna Healthcare1.9329 of 5 stars$7.04-0.6%$6.45-8.4%+37.8%$1.47B$2.02B88.0033,500News CoverageAnalyst UpgradeHigh Trading VolumeTDOCTeladoc Health3.0508 of 5 stars$7.48-0.5%$9.76+30.5%+8.0%$1.32B$2.57B-6.295,500AHCOAdaptHealth4.3501 of 5 stars$9.38-1.1%$13.40+42.9%-4.8%$1.27B$3.26B17.3710,500News CoveragePositive NewsOMDAOmada HealthN/A$20.91+1.9%$24.57+17.5%N/A$1.20B$209.83M0.00849News CoveragePositive News Related Companies and Tools Related Companies Progyny Alternatives Celcuity Alternatives Ardent Health Alternatives PACS Group Alternatives National HealthCare Alternatives Viridian Therapeutics Alternatives Aveanna Healthcare Alternatives Teladoc Health Alternatives AdaptHealth Alternatives Omada Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AGL) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agilon Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agilon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.